The origin and evolution of venom proteins in helodermatid lizards were investigated by multidisciplinary techniques. Our analyses elucidated novel toxin types resultant from three unique domain-expression processes: 1) The first full-length sequences of lethal toxin isoforms (helofensins) revealed this toxin type to be constructed by an ancestral monodomain, monoproduct gene (beta-defensin) that underwent three tandem domain duplications to encode a tetradomain, monoproduct with a possible novel protein fold; 2) an ancestral monodomain gene (encoding a natriuretic peptide) was medially extended to become a pentadomain, pentaproduct through the additional encoding of four tandemly repeated proline-rich peptides (helokinestatins), with the five discrete peptides liberated from each other by posttranslational proteolysis; and 3) an ancestral multidomain, multiproduct gene belonging to the vasoactive intestinal peptide (VIP)/ glucagon family being mutated to encode for a monodomain, monoproduct (exendins) followed by duplication and diversification into two variant classes (exendins 1 and 2 and exendins 3 and 4). Bioactivity characterization of exendin and helokinestatin elucidated variable cardioactivity between isoforms within each class. These results highlight the importance of utilizing evolutionary-based search strategies for biodiscovery and the virtually unexplored potential of lizard venoms in drug design and discovery.
Introduction
Despite a state of fame that extends far beyond the fields of herpetology and natural history, Heloderma suspectum ssp (Gila Monsters) and Heloderma horridum ssp Mexican (beaded lizards) have remained remarkably enigmatic animals. Due to their secretive ecology and persistent folkloristic misconceptions that strongly influenced earlier scientific reports (Brown and Carmony 1999; Beck 2005) , clinical and evolutionary aspects regarding the venom system of Heloderma lizard have long remained controversial. Ambiguities regarding individual toxin types persist even today. For example, the therapeutically useful exendin peptides have been referred to as originating from the ''saliva'' (Bloomgren et al. 2008 ). However, they have in fact only ever been isolated from venom (Parker et al. 1984; Eng et al. 1990 Eng et al. , 1992 , and mRNA coding for these toxins have only been recovered from venom glands (Chen and Drucker 1997; Chen et al. 2002 Chen et al. , 2006 .
Helodermatid lizard venoms are produced by compartmentalized glands on the lower jaw. Recent studies have shown that these glands share an ancient homology with those of other taxa within the reptile clade Toxicofera, which includes snakes and several other lizards recently shown to be venomous (Vidal and Hedges 2005; Fry et al. 2006) . In contrast to the hypothesis of independent venom origins, this new perspective reveals that Heloderma and snake venom systems are homologous, but highly differentiated, descendants of an early evolved venom system in squamates that possessed incipient glands in both the mandibular and maxillary regions. Although snakes subsequently underwent further specialization of the maxillary venom glands and secondarily lost the mandibular ones, the anguimorph lizards (which include helodermatids and varanids) underwent the opposite trend, resulting in specialized mandibular glands (Fry et al. 2006) . Although the Heloderma venom delivery system seems less sophisticated than the high-pressure injection mechanism of the front-fanged advanced snakes, the effect of Heloderma venom may be as clinically complex (Bogert and del Campo 1956; Bouabboud and Kardassakis 1988; Hooker and Caravati 1994; Strimple et al. 1997; Cantrell 2003) with symptoms of Heloderma envenomation including extreme pain, acute local swelling, nausea, fever, faintness, myocardial infarction, tachycardia, hypotension, and inhibition of blood coagulation.
Reptile venom proteins are the result of the duplication of an ordinary body protein, often one involved in a key physiological process, with the subsequent tissue-specific expression of the new gene . It has been previously demonstrated that a core set of venom genes evolved in the common ancestor of the Toxicofera (Fry et al. 2006) . Additional toxin recruitment events facilitated the development into the more complex venoms observed in extant snakes and lizards (cf. Fry et al. 2008) . Currently, six protein-scaffold families have been identified in Heloderma venom (table 1) . Two of these (CRISP and kallikrein) are homologous to proteins found in snake and other venoms, whereas the others are either shared with varanid lizard venoms (type III phospholipase A 2 ) or currently known only from Heloderma venoms (exendin and lethal toxin). Functionally important toxin types are reinforced through adaptive evolution involving explosive duplication and diversification, creating a venom gland specific multigene family. The likelihood for neofunctionalization is increased through random mutation, gene conversion, and unequal crossing-over (Fry et al. 2003) . Although the molecular scaffold of the ancestral protein is conserved, derived activities emerge through mutations of the surface chemistry (de la Vega et al. 2003; Fry et al. 2003; Mouhat et al. 2004; Fry 2005) .
In addition to evolutionary tinkering of ancestral molecular scaffolds, toxin diversity has been shown to be obtained in snake venoms through much more fundamental processes. This is characterized either by selective expression of a monodomain from an ancestral multidomain-encoding gene through exon deletion or a newly multidomain, multiproduct encoding gene evolving from a monoproduct, monodomain gene ( fig. 1 ). The multidomain, multiproduct encoding SVMP (snake venom metalloprotease) gene (cf., Serrano 2008, 2009 ) is a particularly fascinating example of the former as two variants of selective domain expression having been independently derived: the propeptide domain in P-III type SVMP selectively expressed in Psammophis mossambicus venom with newly evolved cysteine bonds ( fig. 1A) (Fry et al. 2008) ; and the P-II SVMP disintegrin domain selectively expressed in Viperidae venoms ( fig. 1B) (cf. Calvete et al. 2005 ). An example of a multidomain, multiproduct gene evolving from a monodomain, monoproduct gene is the sarafotoxin type from Atractaspis venom (cf. Takasaki et al. 1988 ; (Mochcamorales et al. 1990; Morrissette et al. 1995; Nobile et al. 1994 Nobile et al. , 1996 Blockage of ryanodine receptors and potassium channels producing lethargy, paralysis, and hypothermia Exendin 1
Heloderma suspectumssp P04203 (Parker et al. 1984) Induction of hypotension-mediated by relaxation of cardiac smooth muscle (Grundemar and Hakanson 1992; Uddman et al. 1999; Tsueshita et al. 2004 ) and this study Exendin 2 H. suspectum ssp, Heloderma suspectum cinctum P04204 (Parker et al. 1984 ); This study: EU790960 Induction of hypotension mediated by relaxation of cardiac smooth muscle (Grundemar and Hakanson 1992; Uddman et al. 1999; Tsueshita et al. 2004) Heloderma Venom Proteins · doi:10.1093/molbev/msp251 MBE their common venomous ancestor (Fry et al. 2006 ) but is also a prerequisite for insight into the structure, function, and composition of the ancestral Toxicofera venom system and how multiple lineages achieved evolutionary innovations. A thorough understanding of the molecular and functional diversity is also necessary in order to fully exploit the therapeutic potential of these venoms. In this study, we integrated transcriptome with proteome data to provide an in-depth investigation of the molecular evolution of Heloderma venom. Conspicuously, our analyses identify multiple domain selective expression strategies that resulted in the origin of novel toxin types.
Materials and Methods

cDNA Library Construction and Analysis
In order to investigate the relationship between toxins and the encoding transcripts and also facilitate molecular evolutionary analyses, a venom gland cDNA library was constructed to obtain full-length toxin-encoding transcripts from a Heloderma suspectum cinctum (banded Gila monster) specimen using the Qiagen RNeasy Midi Kit with subsequent selection of mRNAs using the Oligotex Midi Kit. cDNA libraries were constructed using the Clonetech Creator SMART cDNA library construction kit and transformed into one shot electrocompetent GeneHogs (Invitrogen Corporation, United States). Isolation and sequencing of inserts were conducted at the Australian Genome Research Facility, using BDTv3.1 chemistry with electrophoretic separation on an AB330xl. Three hundred and eighty-four colonies were sequenced, inserts screened for vector sequences, and those parts removed prior to analysis and identification.
Toxin sequences were identified by comparison of the translated DNA sequences with previously characterized toxins using Blast search of the Swiss-Prot/Uni-Prot protein database (http://www.expasy.org/tools/blast/). Molecular phylogenetic analyses of toxin transcripts were conducted using the translated amino acid sequences. Comparative sequences from other venomous reptiles and outgroups were obtained through Blast searching (http://www. expasy.org/tools/blast/) using representative toxin sequences. To minimize confusion, all sequences obtained in this study are referred to by their Genbank accession numbers (http://www.ncbi.nlm.nih.gov/sites/entrez?db5Nucleotide) and sequences from previous studies are referred to by their UniProt/Swiss-Prot accession numbers (http://www.expasy. org/cgi-bin/sprot-search-ful). Resultant sequence sets were aligned using the program ClustalX, followed by visual inspection for errors. When presented as sequence alignments, leader sequence shown in lowercase, prepro region underlined, cysteines highlighted in black, functional residues in bold. Data sets were analyzed using Bayesian inference implemented on MrBayes, version 3.0b4. The analysis was performed by running a minimum of 1 Â 10 6 generations in four chains and saving every 100th tree. The log-likelihood score of each saved tree was plotted against the number of generations to establish the point at which the log-likelihood scores of the analysis reached their asymptote and the posterior probabilities for clades established by constructing a majority rule consensus tree for all trees generated after the completion of the burn-in phase. Sequence alignments can be obtained by emailing Dr Bryan Grieg Fry (bgf@unimelb.edu.au).
Bioactivity Characterization of Exendin, Helokinestatin, and Natriuretic Peptides Peptide Isolation and Synthesis. In order to investigate structure-function relationships, we isolated and characterized or synthesized variants of exendin, helokinestatin, and natriuretic peptides. Following the recent discovery of Helokinestatin-1 (Kwok et al. 2008) , in this study two, more isoforms were isolated and characterized from the same H. horridum and H. suspectum venom stocks used in the previous study. Thirty-five milligrams of venom (dry weight) was reconstituted in 3 ml of 2 M acetic acid, clarified by centrifugation, and applied directly to a 90-cm Â 1.6-cm column of Sephadex G-50 (fine) column calibrated with Blue Dextran (V 0 ) and potassium dichromate (V t ), equilibrated in 2 M acetic acid and eluted at a flow rate of 10 ml/h. Fractions (2.5 ml) were collected at 15-min intervals. Gel permeation chromatographic fractions 55-65, (500 ll of each fraction) were pooled and subjected to reversedphase high-performance liquid chromatography (HPLC) fractionation using a Thermoquest gradient HPLC system fitted with a Jupiter semipreparative C-5 column (30 cm Â 1 cm). This was eluted with a linear gradient formed from 0.05/99.5 (v/v) triflouroacetic acid (TFA)/ water to 0.05/19.95/80.0 (v/v/v) TFA/water/acetonitrile (ACN) in 240 min at a flow rate of 1 ml/min. Fractions (1 ml) were collected at minute intervals, and the effluent absorbance was continuously monitored at k 214 nm. Samples (100 ll) were removed from each fraction in triplicate, lyophilized, and stored at À20°C prior to smooth muscle pharmacological analysis. Isolated peptides were analyzed using matrix-assisted laser desorption/ionization, time-offlight mass spectrometry (MALDI-TOF MS) on a linear time-of-flight Voyager DE mass spectrometer (Perseptive Biosystems, MA, United States in positive detection mode using alpha-cyano-4-hydroxycinnamic acid as the matrix. Internal mass calibration of the instrument with known standards established the accuracy of mass determination as ±0.1%. After determination of sample purity and molecular mass, the peptide was subjected to MS/MS fragmentation and de novo sequence analysis using a Q-TOF Ultima mass spectrometer (Micromass, Manchester, United Kingdom) and was subjected to conventional amino acid sequence analysis by automated Edman degradation using an Applied Biosystems 491 Procise microsequencer with pulsed-liquid chemistry. The limit for detection using this system was 0.2 pmol.
Helokinestatin and natriuretic peptide sequences in this study and the previously reported exendin peptides 1-4 (Swiss-Prot/Uni-Prot accession numbers P04203, P04204, P20394, and P26349) were synthesized on a CEM Liberty peptide synthesizer using Fmoc solid-phase peptide Fry et al. · doi:10.1093/molbev/msp251 MBE chemistry. The peptides were cleaved from the solid-phase resin with TFA/H 2 O/triisopropylsilane/3,6-dioxa-1,8-octanedithiol (90:2.5:2.5:5) for 2 h. The crude peptides were isolated by ether precipitation, dissolved in 30/70, v/v, ACN/H 2 O, and lyophilized. The crude linear peptides were reversed-phase HPLC purified (Agilent 1200 HPLC System) before forming the single disulfide-bond (in the natriuretic peptide only) by treatment with dipyridyldithiol (1 equiv) in 100 mM ammonium acetate (peptide concentration 1mg/ml, 30 min). The pure cyclized natriuretic peptide was isolated by directly applying the ammonium acetate solution to a reversed-phase HPLC column, isolating pure peptide fractions and lyophilization of the products. The identity of the pure cyclized peptide was confirmed by high-resolution mass spectrometry on an Agilent QTOF 6510 LC/MS mass spectrometer.
Anesthetized Rat Studies. Male Sprague-Dawley rats were anesthetized with pentobarbitone sodium (60-100 mg/kg; i.p.). A midline incision was made in the cervical region and cannulae inserted into the trachea, jugular vein, and carotid artery, for artificial respiration (if required), administration of peptides and measurement of blood pressure, respectively. Arterial blood pressure was recorded using a Gould P23 pressure transducer connected to a PowerLab system. All results were expressed as change in mean arterial pressure (MAP).
Guinea-Pig Isolated Ileum Studies. Guinea pigs of either sex were killed by CO 2 inhalation and exsanguination. The ileum was removed and cut into 2-cm segments. Segments of ileum were then mounted on wire tissue holders under 1-g resting tension in 5-ml organ baths containing physiological salt solution of the following composition (in mM): NaCl 118.4; KCl 4.7; MgSO 4 1.2; KH 2 PO 4 1.2; NaHCO 3 25.0; glucose 11.1; and CaCl 2 2.5, continuously bubbled with carbogen (95% O 2 ; 5% CO 2 ) and maintained at 34°C. The preparation was allowed to equilibrate for 30 min. A cumulative concentration-response curve to bradykinin (1 nM-1 lM) using half-log unit increments was then obtained. The peptide (0.1 lM) was then added and left to equilibrate for 30 min. A cumulative concentration-response curve to bradykinin (1 nM-1 lM) was then repeated, in the presence of the peptide, as described above. Isometric contractions were measured via a Grass force-displacement transducer (FT03) and recorded using a Powerlab system. Responses to bradykinin in the presence of the peptide were expressed as a % of the maximum response obtained from the initial bradykinin curve.
Rat isolated Aorta. Male Sprague-Dawley rats were killed by CO 2 inhalation and exsanguination. The thoracic aorta was removed, cleaned of surrounding connective tissue, and cut into 5-mm rings. Aortic rings were mounted in organ baths containing physiological solution (as above). The aortic rings were maintained at 37°C and suspended between wire hooks at a resting tension of 10 g. Isometric contractions were measured by a Grass forcedisplacement transducer (FT03) and recorded using a Powerlab. Tissues were precontracted with phenylephrine (10 lM) and, at the plateau of contraction, relaxation responses to peptides obtained. 
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Results
Novel Toxin Isoforms and Precursors in the Helodemma Venom Transcriptome
cDNA clones were found that covered the entire precursor sequences of orthologs of the short lethal toxin-1 fragment (Q7LZ31) previously isolated from the venom of Heloderma horridum Horridum (Komori et al. 1988) , showing it to be constructed of beta-defensin domain repeats ( fig. 2) , with us thus giving this class of toxins the name ''helofensins.'' Molecular weights (kDa) and calculated pIs for the three isoforms were 16.884/8.65 (EU790964), 17.815/8.78 (GQ918270), and 16.795/8.84 (GQ918271). Another domain modification identified was that five peptide toxins (natriuretic peptide plus four helokinestatins) are encoded by a single mRNA transcript evolved from the monodomain natriuretic ancestral sequence ( fig. 3) . One helokinestatin peptide (helokinestatin-1) was previously purified from the venom (Kwok et al. 2008) , and the others were purified from the venom in this study, thus allowing for determination of posttranslational cleavage sites in the translated form of the full-length mRNA transcript also recovered in this study. The first three helokinestatin isoforms were similar in sequence (GPPYQPLVPR, VPPAYVPLVPR, and VPPPPLQMPLIPR, respectively) and separated by a conserved ASDEN linker sequence ( fig. 3) . A linker sequence ASEQKGPPFN separates a fourth bioactive helokinestatin variant (PPPFVDYEPR), which has only one proline bracket rather than the two brackets characteristic of the other three peptides. In addition, we found a novel precursor transcript that encodes a closely related isoform of exendin 2. Despite the considerable difference in sequence and activity, this precursor sequence of the exendin 2 isoform obtained here shows overall high structural similarity to the precursors of exendins 3 and 4 ( fig. 4) . This is especially the case for the signal peptide, which differs in only 3 amino acids (14.3%) from that of exendin 3. For exendins, our analyses recover all known toxins and precursors in a single clade within the glucagon/vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating polypeptide (PACAP) protein family ( fig. 5 ).
Bioactivity Testing
The exendin toxins were shown to have variable degrees of cardioactivity ( fig. 6A and B) , with exendins 1 and 2 being MBE more similar to each other and more potent than exendins 3 and 4 (which were also similar to each other) or the Heloderma body peptide GLP-1 (which was slightly more active than exendins 3 and 4). Reflective of significant sequence differences among the four helokinestatin peptides, helokinestatins-2, -3, and -4 were less potent than helokinestatin-1 at inhibiting contractile responses to bradykinin in the guinea-pig ileum and showed similar variable antagonist activity at bradykinin B2 receptors, with helokinestatin-1 again being the most potent ( fig. 6C) . Fry et al. 2006 Fry et al. , 2008 Wagstaff and Harrison 2006) . The availability of entire cDNA precursor sequences rather than just the processed protein forms allows for largely improved phylogenetic analyses. This provides new insights into the molecular evolutionary origins of the individual Heloderma toxin types. Our results thus allowed us to elucidate unique domain-expression processes utilized to generate novel toxin forms.
Novel Toxin Types Produced through Gene Domain Mutation
Helofensins. This class was previously known only from a short fragment (Q7LZ31) which, due to its small size MBE and sequence ambiguity for certain residues, did not permit meaningful homology searches. The 24 cysteine fulllength precursor sequence of the isoforms obtained here resolves previously ambiguous residues (marked with x in fig. 2 ) as either cysteines (x1 and x3 being cysteines one and two, respectively) or asparagine (x2). Furthermore, two additional residues previously reported as arginine are identified here as cysteines three and four, respectively. The corresponding region of one of our sequences (EU790964) did not differ otherwise with the Q7LZ31 fragment. However, it must be noted that the calculated molecular weight of our isoforms are in conflict with the reported 28-kDA proteins in previous studies using gel-based molecular weight determination (Komori et al. 1988) .
Our Blast searches and phylogenetic analyses identify helofensins as being extremely derived forms of the beta-defensin gene type. Helofensin isoforms have descended from an ancestral beta-defensin precursor that underwent three domain duplications to produce a single gene encoding four tandem repeats of the original domain ( fig. 7A ). As these four tandem-repeated domains encode a single peptide, this almost certainly results in a new and more complex protein fold. Each of these domains has subsequently undergone significant molecular evolution with changes in cysteine spacing and pattern as well as fundamental biochemical changes such as charge distribution. The cysteine pattern and spacing of the four repeats are conserved: C(6)C(4)C(9)C(6)CC, C(6)C(4)C(9)C(5)CC, C(6)C(4)C(10)C(5)CC, and C(6)C(3)C(11)C(5)CC ( fig. 2) . Only one residue deletion occurs between the four sequences. Charged residues were also highly conserved between the isoforms, with only one of the six residue changes (at alignment position 97) being a charge state reversal. As with the helokinestatin peptides ( fig. 3) , the tandem domain repeats are more degenerate downstream. These polarities of mutations in repeats suggest that there are upstream constraints/selection to conserve repeat structure at the 5# end. As the beta-defensin domain type utilized is different than that recruited for use in the crotamine toxin multigene family (e.g., O57540), this represents a third utilization of this domain for use as a toxin, with the platypus toxin being the other distinct type (e.g., P82172).
Natriuretic Peptides. The ancestral monodomain natriuretic gene was mutated to additionally encode medially for four versions of helokinestatin peptides ( fig. 3) , with the five peptides liberated from each other by posttranslational proteolysis ( fig. 7B ). Such novel domains are absent from the homologous natriuretic peptides found in varanids (Fry et al. 2006 (Fry et al. , 2009 , but it remains to be determined whether they are present in the forms of the more closely related anguiid lizards. The helodermatid lizards have thus convergently evolved trandemly repeated proline-rich bioactive peptides (the helokinestatin peptides) in the same upstream region of the natriuretic gene (between the signal peptide and the natriuretic peptide-encoding domain) as has occurred with the (also posttranslationally liberated) BPPs in pit-viper venoms (cf. Soares et al. 2005 ) and metalloprotease-inhibiting peptides in the Echis genus of true vipers (Wagstaff et al. 2008) (fig. 3) .
Exendin Peptides. Exendin toxins pose a fascinating molecular evolutionary riddle. Although exendins 1 and 2 are similar to the second domain of the VIP precursor (corresponding to the VIP peptide itself), exendins 3 and 4 are structurally related to either the first or third domain of the glucagon precursor (fig. 4) . In contrast, the strong similarity of the signal peptides and the prepro region of the two pairs of exendin-toxin types is indicative of a shared evolutionary history, pointing toward a common origin by a mono recruitment event. We propose three alternative evolutionary scenarios to explain the observed pattern conflict, each involving different genetic mechanisms.
A first scenario, unlikely in light of our phylogenetic results ( fig. 5) , involves an independent phylogenetic origin for each of the exendin types ( fig. 8A ). One pair of exendins (exendins 1 and 2) descending from a single toxin gene that duplicated from a VIP/PACAP-like precursor gene, whereas the second pair (exendins 3 and 4) descending from the glucagon-like precursor gene. Because both pairs represent This scenario implies independent domain losses, and an exon-shuffling event to explain the closely related signal peptides among the two pairs and is unlikely in light of our phylogenetic results favoring a mono origin of exendin peptides. (B) A second scenario implies a monoexendin ancestor that duplicated from an unknown multidomain hormone precursor gene. The monoexendin ancestor subsequently underwent domain loss, and multiple successive gene duplication events to obtain four monodomain exendin genes. (C) Alternatively, an unknown multidomain ancestor was split into two tandem genes by interdomain insertion of a signal peptide through exon shuffling, and each tandem gene subsequently underwent an additional gene duplication to obtain the four exendin genes. Fry et al. · doi:10.1093/molbev/msp251 MBE truncated (monodomain) precursors while all known hormone precursors in this protein family have multiple domains (VIP/PACAP precursors typically contain two domains; glucagons precursors typically have three), this implies that their respective ancestral genes independently lost one and two domain-encoding exons, respectively, to obtain their monodomain-encoding genes. In addition, dual origins would imply that the nearly identical signal peptides shared by all the exending peptides resulted from an exon-shuffling event, that is, the transfer of the signal peptide-encoding exon from one ancestral exendin to that of the other, followed by another duplication round for each exendin type. The most common mechanisms currently implicated to explain exon shuffling in eukaryotes are interlocus gene conversion (nonreciprocal recombination) and retrotransposition. Recent studies have suggested that interlocus gene conversion is most common between linked loci (on the same chromosome), and its frequency is inversely proportional to the distance between the involved loci (Ezawa et al. 2006) . However, if the two pairs of exendin evolved independently from VIP and glucagon ancestors, it is unlikely that they are spatially linked. Screening of the genome maps of various vertebrates reveals that the glucagon and VIP genes are situated on different chromosomes in zebra fish (chromosomes 22 and 13, respectively), chicken (chromosomes 7 and 3), rat (chromosomes 3 and 1), and human (chromosomes 2 and 6), suggesting an ancient genomic separation of the two genes. This would imply that the VIP and glucagon genes (and any recently derived paralogs) are likely to lie on different chromosomes in Heloderma as well. An exon shuffling origin for the exendin signal peptides would therefore imply an interchromosomal (ectopic) gene-conversion event or a retrotransposition event. In summary, a dual origin of the two exendin gene pairs would not only imply two independent toxin recruitment events and subsequent domain losses but also an extremely rare interchromosomal exonshuffling event.
A second scenario implicates a single evolutionary origin of exendins, as suggested by our phylogenetic analyses, with the sole founding gene either VIP ( fig. 8B ) or glucagon derived ( fig. 8B# ). Under this scenario, a single ancestral multidomain precursor gene lost one (VIP as the starting material) or two domains (glucagon as the starting material) through exon deletion(s). The structural similarities of the two exendin pairs with different hormone peptides suggest substantial convergent evolution within the peptide-encoding regions to explain their present structural variation. The timing of this would be best explained as occurring to one duplicate after the first gene duplication round subsequent to the toxin recruitment event, with another round of gene duplication producing the two exendin pairs
The third scenario, like scenario two, also implicates a single origin of exendins, again consistent with our phylogenetic analyses. This scenario involves a different type of domain mutation to explain the currently observed peptide variation, again with the sole founding gene either VIP ( fig. 8C) or glucagon derived (fig. 8C# ). Under these scenarios, the single ancestral multidomain precursor gene was split into two tandem genes by insertion of its signal peptide in between two of the peptide-encoding domains through exon shuffling (e.g., as a result of unequal crossing-over). The two tandem genes subsequently duplicated again, each giving rise to one of the presently observed exendin pairs. This scenario as well requires substantial convergent amino acid substitutions to explain their similarities with different hormones, with the timing occurring either just before or just after the gene splitting but before the first gene duplication round subsequent to the toxin recruitment event. This scenario would also require an exon deletion if glucagon is the starting material ( fig. 8C#) .
The first scenario is excluded by our phylogenetic analyses and also the unlikeliness of interchromosomal exon shuffling. However, the final distinction between the second and third scenarios will require insights into the genomic organization of exendins and their closely related glucagon family genes. Regardless, both the second and third scenarios would require that the ancestor of at least one of the two exendin pairs underwent substantial convergent evolution with either of the hormone clades to obtain their present structural variation. Endogenous VIP hormones have been shown to be more potent vasodilators than endogenous glucagon hormones (Ezawa et al. 2006) . As a consequence, a peptide that mimics a generalized VIP hormone may provide a more effective toxin. The results of this study demonstrate that exendins 1 and 2 have a higher cardioactivity than exendins 3 and 4 and also the nontoxin peptide GLP-1 (O12956) ( fig. 6A and B) . This is in agreement with other studies on exendins 1 and 2 that demonstrated vasodilatory actions similar to VIP (Uddman et al. 1999; Tsueshita et al. 2004 ). The molecular evolution from a less potent (glucagon-like) form toward a more potent (VIP-like) form is more plausible than the converse. The origin of exendin peptides thus favors a glucagon-like ancestor with subsequent divergence of one duplicate to convergently become a VIP-like toxin ( fig. 8B# or C#) . The timing of these molecular evolutionary events however remains to be resolved. Glucagon-like exendins 3 and 4 have been isolated from both H. suspectum and H. horridum, whereas the VIP-like 1 and 2 have only been isolated from H. suspectum. This would thus favor a basal glucagonderived exendin type as shown in figure 8B# with a subsequent VIP-like convergence specific to H. suspectum. However, the absence of evidence is not necessarily evidence of absence. Thus, exhaustive sequencing of the H. horridum venom transcriptome must be undertaken before the concluded absence of the VIP-like exendins 1 and 2 peptides can be considered as adequately supported. If exendins 1 and 2 peptides are in fact present in the venom of H. horridum, this would still support a glucagon basal peptide but would not allow for distinguishing between scenario B# or C# in figure 8 without genomic understanding of the toxins and their nontoxin ancestors.
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Conclusion
Our precursor sequences reveal previously undetected molecular evolutionary patterns in Heloderma toxins that provide interesting starting points for studies focusing on the genetic mechanisms that underlie toxin diversification in any venomous taxon. Multiple toxin isoforms in Heloderma venom were not only attained by conventional gene duplication events but also by different forms of domain mutation. First, helofensins represent an example of a new multidomain, monoproduct gene that evolved by multiple tandem domain duplications from an ancestral monodomain gene ( fig. 7A) . Second, the gene encoding for natriuretic peptides plus four additional peptides is an example of a multidomain, multiproduct gene that emerged from an ancestral monodomain, monoproduct gene by domain insertion and subsequent domain duplications ( fig. 7B ). Finally, exendins represent an example of monodomain, monoproduct genes that either evolved by domain deletion from a multidomain, multiproduct gene, or by the splitting of the ancestral multidomain, multiproduct gene to encode for two new monodomain, monoproduct genes followed by insertion of a signal peptide through exon shuffling ( fig. 8) .
The findings of the present study combined with the information available from the literature (Beaman et al. 2006 ) reveal how little we still know about the toxinology of the enigmatic Heloderma lizards. With respect to their venoms, we do not know enough of composition, role of individual venom components in prey capture, or in vitro activities relative to subsequent physiological sequelae following envenomation. We would also like to emphasize that these species belong to an ever-growing group of threatened species that may affect biodiversity and cause an important loss of genetic information. We, therefore, hope that this study will not only stimulate further research and provide a new understanding and realization of conservation efforts but will also encourage the utilization of this precious natural resource in a sustainable and ethical manner.
